Skip to main content
ENSC
NASDAQ Life Sciences

Ensysce Biosciences Secures $2M Convertible Preferred Financing, Funds Pain Programs

Tom Rudovsky · Reported by Access Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.548
Mkt Cap
$5.187M
52W Low
$0.314
52W High
$4.85
52W Position info
74% above low
Off High info
89% below high
Rel. Volume
Market data snapshot near publication time

ENSC sits 74% above its 52-week low of $0.314.

Summary

Ensysce Biosciences has secured a $2 million convertible preferred stock financing, representing the second tranche of a larger $20 million commitment established in November 2025. This capital infusion, which includes a fixed conversion price of $0.55 per share and 100% warrant coverage, is earmarked to advance the company's breakthrough pain programs and support general corporate initiatives. For a company with a market capitalization of just over $5 million, this $2 million financing is highly material and carries significant potential for dilution for existing shareholders, despite providing necessary operational funding. This financing follows recent director resignations and the release of Q4/FY25 financial results, underscoring the company's ongoing need for capital. Investors should monitor the impact of future conversions and warrant exercises on the share structure, as well as progress in their clinical pipeline.

At the time of this announcement, ENSC was trading at $0.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.2M. The 52-week trading range was $0.31 to $4.85. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Access Newswire.


Price Chart

Share this article

Copied!

ENSC - Latest Insights

ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.3421 info
Change: -$0.0298 (-8%) info
Market Cap: $6.656M info
ENSC
Oct 30, 2026, 5:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4313
Real-time Price: $0.3421 info
Change: -$0.0892 (-21%) info
Market Cap: $6.656M info
ENSC
Oct 23, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.4847
Real-time Price: $0.3421 info
Change: -$0.1426 (-29%) info
Market Cap: $6.656M info
ENSC
Oct 15, 2026, 9:56 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.565
Real-time Price: $0.3421 info
Change: -$0.2229 (-39%) info
Market Cap: $6.656M info
ENSC
Aug 25, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3905
Real-time Price: $0.3421 info
Change: -$0.0484 (-12%) info
Market Cap: $6.656M info